HCM
Hayman Capital Management Portfolio holdings
AUM
$42M
This Quarter Return
+2.22%
1 Year Return
-14.19%
3 Year Return
-42.4%
5 Year Return
–
10 Year Return
–
AUM
$622M
AUM Growth
+$622M
(+892%)
Cap. Flow
+$559M
Cap. Flow
% of AUM
89.8%
Top 10 Holdings %
Top 10 Hldgs %
60.27%
Holding
40
New
11
Increased
23
Reduced
–
Closed
–
Top Buys
| 1 |
Perrigo
PRGO
|
$155M |
| 2 |
Viatris
VTRS
|
$52.9M |
| 3 |
Chord Energy
CHRD
|
$17.8M |
| 4 |
WLL
Whiting Petroleum Corporation
WLL
|
$17.7M |
| 5 |
NFX
Newfield Exploration
NFX
|
$17.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Energy | 47.94% |
| 2 | Healthcare | 35.51% |
| 3 | Financials | 7.08% |
| 4 | Materials | 1.99% |
| 5 | Consumer Discretionary | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Halliburton
HAL
$19.4B
| $11.5M | 1.36% | 267,148 +254,570 | +2,024% | +$11M |
|
27
Helmerich & Payne
HP
$2.08B
| $10M | 1.19% | 142,616 +134,597 | +1,678% | +$9.48M |
|
28
General Motors
GM
$55.8B
| $4.2M | 0.5% | 125,967 | – | – |
|
29
Bausch Health
BHC
$2.74B
| $2.27M | 0.27% | +10,198 | New | +$2.27M |
|
30
Pfizer
PFE
$141B
| $2.14M | 0.25% | +63,675 | New | +$2.14M |
|
31
Merck
MRK
$210B
| $2.02M | 0.24% | +35,404 | New | +$2.02M |
|
|
ENDP
32
DELISTED
Endo International plc
ENDP
| $1.97M | 0.23% | +24,779 | New | +$1.97M |
|
33
BioMarin Pharmaceuticals
BMRN
$11.2B
| $1.35M | 0.16% | +9,886 | New | +$1.35M |
|
34
Eli Lilly
LLY
$657B
| $1.3M | 0.15% | +15,529 | New | +$1.3M |
|
35
Regeneron Pharmaceuticals
REGN
$61.5B
| $1.28M | 0.15% | +2,506 | New | +$1.28M |
|
36
Vertex Pharmaceuticals
VRTX
$100B
| $1.11M | 0.13% | +8,949 | New | +$1.11M |
|
|
VRS
37
DELISTED
VERSO CORP COM STK (DE)
VRS
| $540K | 0.06% | 818,670 | – | – |
|
38
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
39
YPF
YPF
$12B
| – | – | 0 | – | – |
|
|
RCAP
40
DELISTED
RCS CAPITAL CORPORATION CLASS A COM
RCAP
| – | – | 0 | – | – |
|